Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2022 | The role of ER-phagy in multiple myeloma cell survival

Simone Cenci • 26 Aug 2022
IMS 2022
Multiple Myeloma

Simone Cenci, MD, IRCCS Ospedale San Raffaele, Milan, Italy, comments on the role of endoplasmic reticulum autophagy (ER-phagy) in the survival of multiple myeloma cells, highlighting the potential of manipulating this mechanism as a novel therapeutic strategy. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Simone Cenci

1:44
Targeting mitochondrial vulnerabilities in multiple myeloma
Simone Cenci • 26 Aug 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals